Terns Pharmaceuticals (NASDAQ: TERN) had a more memorable March than a great many other companies on U.S. stock exchanges.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is among the 13 Cheapest Strong Buy Stocks to Buy Right Now. On March 30, ...

The young drugmaker's sickle cell treatment is receiving special consideration from the United States' top drug regulator.

Spun off from a Dividend King in 2013, this pharmaceutical stock is a rising star among dividend growth stocks.

Neurocrine Biosciences stock fell after the merger was announced.

Telix Pharmaceuticals delivered strong Q1'26 results with $230M revenue and reaffirmed FY26 guidance of $950–$970M, above ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of Billionaire Stan Druckenmiller’s 10 Small and Mid-Cap Stock ...

While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...

However, there is one key reason the stock could still deliver outstanding returns over the long run: Its pipeline could help ...

Inovio Pharmaceuticals Inc. INO shares are up during Tuesday’s premarket session as the company announced a public offering ...

Since then, the stock has delivered market-beating returns thanks to significant clinical and regulatory progress, as well as ...

Pharma stocks have, so far, outperformed the markets in 2026. However, as risk around Trump tariffs resurface, analysts ...